Tech Company Financing Transactions

Axial Biotherapeutics Funding Round

Axial Biotherapeutics, operating out of Woburn, raised $10 million from Taiho Ventures.

Transaction Overview

Announced On
6/21/2019
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series B
Investors

Taiho Ventures (Sakae Asanuma)

Proceeds Purpose
In conjunction with this investment, Axial will maintain control of the new oncology programs and Taiho Ventures will have a first right to negotiate for an exclusive license related to the new programs.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Tradecenter Dr. 6990
Woburn, MA 01801
USA
Email Address
Overview
Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and Central Nervous System to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.
Profile
Axial Biotherapeutics LinkedIn Company Profile
Social Media
Axial Biotherapeutics Company Twitter Account
Company News
Axial Biotherapeutics News
Facebook
Axial Biotherapeutics on Facebook
YouTube
Axial Biotherapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Stewart Campbell
  Stewart Campbell LinkedIn Profile  Stewart Campbell Twitter Account  Stewart Campbell News  Stewart Campbell on Facebook
Chief Financial Officer
Jeffrey Young
  Jeffrey Young LinkedIn Profile  Jeffrey Young Twitter Account  Jeffrey Young News  Jeffrey Young on Facebook
Vice President
Federico Bolognani
  Federico Bolognani LinkedIn Profile  Federico Bolognani Twitter Account  Federico Bolognani News  Federico Bolognani on Facebook
VP - Finance
Maura Moroni
  Maura Moroni LinkedIn Profile  Maura Moroni Twitter Account  Maura Moroni News  Maura Moroni on Facebook
VP - Operations
Chris Meyer
  Chris Meyer LinkedIn Profile  Chris Meyer Twitter Account  Chris Meyer News  Chris Meyer on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/21/2019: Rhumbix venture capital transaction
Next: 6/24/2019: JenaValve Technology venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary